A Prospective Study Evaluating Maternal and Fetal Outcomes in the Era of Modulators (MAYFLOWERS)

Protocol No

PULM-CFF-MAYFLOWERS-OB-20

Phase

N/A

Summary

In this study, the investigators aim to evaluate changes in lung function in women with cystic fibrosis (CF) during pregnancy and for 2 years after pregnancy based on exposure to highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators.

Description

Prospective Study of Pregnancy in Women With Cystic Fibrosis

Participating Institutions

Froedtert Hospital

Status

OPEN TO ACCRUAL